Toho Holdings Company Limited operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Toho Holdings Company Limited with three other
drug stores in Asia:
Hokuyaku Takeyama Holdings, Inc
sales of 227.79 billion Japanese Yen [US$2.06 billion]
of which 70%
was Pharmaceutical Business),
Vital KSK Holdings Incorporation
(565.59 billion Japanese Yen [US$5.11 billion]
of which 95%
was Pharmaceuticals Sales), and
Suzuken Co., Ltd.
(2.12 trillion Japanese Yen [US$19.18 billion]
of which 93%
was Pharmaceutical Wholesale Business).
During the year ended March of 2018, sales at
Toho Holdings Company Limited were ¥1.21 trillion (US$10.96 billion).
decrease of 1.4%
versus 2017, when the company's sales were ¥1.23 trillion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Toho Holdings Company Limited had sales
of ¥1.14 trillion.
Contributing to the drop in overall sales was the 1.8% decline
in Pharmaceutical Wholesale Business, from ¥1.13 trillion to ¥1.11 trillion.
However, these declines were partially offset by the increase in sales of
Dispensing Pharmacy Business (up 2.3% to ¥97.65 billion)
Information Equipment Sales (up 10.2% to ¥1.46 billion)
Institutional Support for Clinical Trial (up 0.3% to ¥323.00 million)